Reply to comments on ‘highly antimalaria-active artemisinin derivatives: biological activity does not correlate with chemical reactivity’

Author(s): Haynes RK

Abstract

In light of the discussion on C10-substituted derivatives of the antimalarial agent artemisinin in the preceding correspondence article which relates to his earlier work, R. K. Haynes reiterates here that there is no correlation between the ability of artemisinins to react with heme- or non-heme-FeII and their antimalarial activity. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.

Similar Articles

Medicinal plants in therapy

Author(s): Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z

Burger's medicinal chemistry and drug discovery

Author(s): James F, Kerwin Jr.

Antimalarial drug resistance

Author(s): White NJ

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

Author(s): Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group

Artesunate versus quinine for severe falciparum malaria

Author(s): Woodrow CJ, Planche T, Krishna S

Artemisinins: activities and actions

Author(s): Haynes RK, Krishna S

Artemisone--a highly active antimalarial drug of the artemisinin class

Author(s): Haynes RK, Fugmann B, Stetter J, Rieckmann K, Heilmann HD, et al.

A single amino acid residue can determine the sensitivity of SERCAs to artemisinins

Author(s): Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, et al.

Identification of an antimalarial synthetic trioxolane drug development candidate

Author(s): Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FC, et al.

Synthetic studies towards halichondrins: synthesis of the C

Author(s): Aicher TD, Buszek KR, Fang FG, Forsyth CJ, Jung SH, et al.

Enabling high-throughput discovery

Author(s): Vaschetto M, Weissbrod T, Bodle D, Güner O